Cohance Lifesciences Limited
COHANCE
Classifica tra le azioni
#6383
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Prezzo delle azioni
$5.05
Ultima sincronizzazione: 2026-10-19
Capitalizzazione di mercato
$1.93B
Variazione (1 giorno)
-1.44%
Variazione (1 anno)
-57.38%
Paese
IN
Scambia Cohance Lifesciences Limited (COHANCE)
Categoria
Healthcare
Storico del rendimento da dividendi per Cohance Lifesciences Limited (COHANCE)
Il rendimento da dividendi (TTM) di Cohance Lifesciences Limited (simbolo azionario: COHANCE) al 2024-03-31 è: 0.00%
Rendimento medio negli ultimi 5 anni: 0.51%
Rendimento medio negli ultimi 5 anni: 0.51%
Storico del rendimento da dividendi per Cohance Lifesciences Limited (COHANCE) da 2019 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
| Anno | Rendimento da dividendi | Cambia |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | 0.00% |
| 2024 | 0.00% | -100.00% |
| 2023 | 1.69% | 160.00% |
| 2022 | 0.65% | 225.00% |
| 2021 | 0.20% | -93.33% |
| 2020 | 3.00% | 455.56% |
| 2019 | 0.54% | 0.00% |
Rendimenti da dividendi (TTM) di aziende simili o concorrenti
| Azienda | Rendimento da dividendi | Il paese |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 0.00% |
JP
|
|
| 0.00% |
CH
|
|
| 0.91% |
IN
|
